← Back to headlines
Wells Fargo Identifies AMP-007 as Key to Amphastar Pharmaceuticals' Growth
Wells Fargo analysts believe Amphastar Pharmaceuticals, Inc.'s drug AMP-007 will be crucial for achieving mid- to high-single-digit growth.
2 Mar, 15:23 — 2 Mar, 15:23
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Price freeze on basic goods urged if MidEast conflict drags on
just now
Abuja-Kaduna Highway Nears Completion, Set for April Delivery
just now
Nigerian House of Representatives Moves to Recover $7 Billion from Foreign Airlines
just now
Small Businesses Confused by Trump's Tariffs, Supreme Court Warns of Refund 'Mess'
10m ago